Lehr Martin A. 4
4 · Context Therapeutics Inc. · Filed Feb 14, 2023
Insider Transaction Report
Form 4
Lehr Martin A.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-13+287,544→ 287,544 totalExercise: $0.84Exp: 2033-02-12→ Common Stock (287,544 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.